Clinical Uses of Antiprogestogens

Ulmann A, Teutsch G, Philibert D. RU 486. Sci Am 1990;262;18–24. Van Look PFA, Bygdeman M. Antiprogestational steroid: A new dimension in human fertility regulation. In: Milligan WR, ed. Oxf Revs Reprod Biol 11. Oxford: Oxford University Press, 1989:1–60. Baird DT, Norman JE. Antifertility effects of antigestogens. Reprod Med Rev 1993;2:95–108. Baird DT. Potential contraceptive effects of antigestogens. In: Donaldson M, Dorflinger L, Brown SS, Benet LZ, eds. Clinical applications of mifepristone (RU 486) and other antiprogestins. Washington: National Academy Press, 1993:148–63. Spitz IM, Bardin CW. RU 486—A modulator of progestin and glucocorticoid action. N Engl J Med 1993;329:404–12. Herrmann WL, Schindler AM, Wyss R, Bischof P. Effects of the antiprogesterone RU 486 in early pregnancy and during the menstrual cycle. In: Baulieu EE, Segal SJ, eds. The antiprogestin steroid RU 486 and human fertility control. New York: Plenum Press, 1985:179–98. Couzinet B, Strat NL, Ulmann A, et al. Termination of early pregnancy by the progesterone antagonist RU 486 (mifepristone). N Engl J Med 1986;315:1565–70. Bygdemann M, Swahn M-L. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception 1985;32:45–51. Cameron IT, Michie A, Baird DT. Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with a prostaglandin analogue (Gemeprost). Contraception 1986;34:459–68. Rodger MW, Baird DT. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary. Lancet 1987;ii:1415–8. UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester of pregnancy. Br J Obstet Gynaecol 1990;97:480–6. Ulmann A, Silvestre L, Chemama L, et al. Medical termination of early pregnancy with mifepristone followed by a prostaglandin analogue: Study in 16,369 women. Acta Obstet Gynecol Scand 1992;71:278–83. World Health Organization. Termination of pregnancy with reduced doses of mifepristone. Br Med J 1993;307:532–7. Baird DT, Thong KJ. In: Otteson B, Tabor A, eds. New insights in gynecology and obstetrics research and practice. Camforth, UK: Parthenon Publishing, 1998:193–200. Urquhart DR, Templeton AA. The use of mifepristone prior to prostaglandin-induced midtrimester abortion. Hum Reprod 1990;5:883–6. Rodger MW, Baird DT. Pre-treatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990;97:41–5. Ashok PW, Flett GM, Templeton AA. Termination of pregnancy at 9 to 13 weeks amenorrhoea with mifepristone and misoprostol. Lancet 1998;352:542–3. Frydman R, Baton C, Lelaider C, et al. Mifepristone for induction of labour. Lancet 1991;337:488–9. World Health Organization. Menstrual regulation by mifepristone plus prostaglandin—results from a multicentre trial. Hum Reprod 1995;10:308–15. Swahn M-L, Bygdeman M, Cekans S, et al. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormone parameters and endometrium. Hum Reprod 1990;5:402–8. Gemzell-Danielsson K, Swahn M-L, Svalander P, Bygdeman M. Early luteal phase treatment with RU 486 for fertility regulation. Hum Reprod 1993;8:870–3. Dubis C, Ulmann A, Baulieu E-E. Contragestion with late luteal administration of RU 486 (mifepristone). Fertil Steril 1988;50:593–6. Couzinet B, Le Strat N, Silvestre L, Schaison G. Late luteal administration of the antiprogesterone RU 486 in normal women: Effects on the menstrual cycle events and fertility control in a long term study. Fertil Steril 1990;54:1039–43. Glasier AF, Thong KJ, Dewar M, et al. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992;327:1041–4. Webb AMC, Russell J, Elstein M. Comparison of Yuzpe regimen, danazol and mifepristone (RU 486) in oral postcoital contraception. Br Med J 1992;305:927–31. Danforth DR, Dubois C, Ulmann A, et al. Contraceptive potential of RU 486 by ovulation inhibition: Ill. Preliminary observations on the weekly oral administration. Contraception 1989;40:195–200. Spitz IM, Croxatto HB, Salvatierra A-M, Heikinheimo O. Response to intermittent RU 486 in women. Fertil Steril 1993;59:971–5. Gemzell-Danielsson K, Westlund P, et al. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod 1996;11:256–64. Kekkonen JR, Alfthan H, Haukkama M, et al. Interference with ovulation by sequential treatment with the antiprogesterone RU 486 and synthetic progestin. Fertil Steril 1990;53:747–50. Croxatto HB, Salvatierra AM, Fuentealba B, Massai R. Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women. Hum Reprod 1998;13:3297–302. Ledger WL, Sweeting VM, Hillier H, Baird DT. Inhibition of ovulation by low dose mifepristone (RU 486). Hum Reprod 1992;7:945–50. Croxatto HB, Salvarierra AM, Croxatt HD, Fuentealba B. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum Reprod 1993;8:201–7. Gemzell-Danielsson K, Swahn M-L, et al. Effects of daily doses of mifepristone on ovarian function and endometrial development. Hum Reprod 1997;12:124–31. Batista MC, Cartledge TP, Zellmer AW, et al. Delayed endometrial maturation induced by daily administration of the anti-progestin RU 486; a potential new contraceptive strategy. Am J Obstet Gynecol 1992;167:60–5. Radestad A, Christensen NJ, Stromberg L. Induced cervical ripening with mifepristone in first trimester abortion: A double-blind randomized biomechanical study. Contraception 1988;38:301–12. Kettel LM, Murphy AA, Morales AJ. Treatment of endometriosis with antiprogesterone mifepristone (RU 486). Fertil Steril 1996;65:23–8. Murphy AA, Kettel LM, Morales AJ, et al. Regression of uterine leiomyomata in response to the antiprogesterone RU 86. J Clin Endocrinol Metab 1993;76:513–7.